C B Carpenter|T B Strom - JoVE Visualize

Showing results (101-110 of 322) with videos related to

Pageof 33

Sort By:

European Journal of Immunology|April 1, 1986

Inability of autoimmune mice with the lpr gene to spontaneously produce interleukin 3V E Kelley, N M Farber, J M Williams, et al.

Transplantation|January 1, 1990

Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporineG Walz, B Zanker, L B Melton, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 15, 1992

An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferationC Díaz-Gallo, M Moscovitch-Lopatin, T B Strom, et al.

Science (New York, N.Y.)|July 13, 1973

Microtubule function in immune and nonimmune lymphocyte-mediated cytotoxicityT B Strom, M R Garovoy, D B Carpenter, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986

Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in ratsJ W Kupiec-Weglinski, T Diamantstein, N L Tilney, et al.

Experimental and Clinical Endocrinology|May 1, 1989

Current stage of interleukin 2 receptor targeted therapyT Diamantstein, J W Kupiec-Weglinski, T B Strom, et al.

The Journal of Biological Chemistry|July 15, 1990

Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cellsD P Williams, C E Snider, T B Strom, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984

Accessory cell requirement for activation antigen expression and cell cycle progression by human T lymphocytesJ M Williams, B J Ransil, H M Shapiro, et al.

Protein Engineering|April 1, 1992

Phe496 and Leu497 are essential for receptor binding and cytotoxic action of the murine interleukin-4 receptor targeted fusion toxin DAB389-mIL-4F Lakkis, B Landgraf, Z Wen, et al.

Transplantation|December 1, 1982

Late mortality and morbidity in recipients of long-term renal allograftsR L Kirkman, T B Strom, M R Weir, et al.

Pageof 33

Showing results (101-110 of 322) with videos related to

Sort By:

Pageof 33

European Journal of Immunology|April 1, 1986

Inability of autoimmune mice with the lpr gene to spontaneously produce interleukin 3V E Kelley, N M Farber, J M Williams, et al.

Transplantation|January 1, 1990

Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporineG Walz, B Zanker, L B Melton, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 15, 1992

An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferationC Díaz-Gallo, M Moscovitch-Lopatin, T B Strom, et al.

Science (New York, N.Y.)|July 13, 1973

Microtubule function in immune and nonimmune lymphocyte-mediated cytotoxicityT B Strom, M R Garovoy, D B Carpenter, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986

Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in ratsJ W Kupiec-Weglinski, T Diamantstein, N L Tilney, et al.

Experimental and Clinical Endocrinology|May 1, 1989

Current stage of interleukin 2 receptor targeted therapyT Diamantstein, J W Kupiec-Weglinski, T B Strom, et al.

The Journal of Biological Chemistry|July 15, 1990

Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cellsD P Williams, C E Snider, T B Strom, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984

Accessory cell requirement for activation antigen expression and cell cycle progression by human T lymphocytesJ M Williams, B J Ransil, H M Shapiro, et al.

Protein Engineering|April 1, 1992

Phe496 and Leu497 are essential for receptor binding and cytotoxic action of the murine interleukin-4 receptor targeted fusion toxin DAB389-mIL-4F Lakkis, B Landgraf, Z Wen, et al.

Transplantation|December 1, 1982

Late mortality and morbidity in recipients of long-term renal allograftsR L Kirkman, T B Strom, M R Weir, et al.

Pageof 33